Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Carducci MA, Padley RJ, Breul J, Vogelzang NJ, Zonnenberg BA, Daliani DD, Schulman CC, Nabulsi AA, Humerickhouse RA, Weinberg MA, Schmitt JL, Nelson JB, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD: J Clin Oncol 2003;21:679–689

Autor: Trump, Donald L

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2003 21(5):410-411

Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy

Autor: Toth PP, Thakker KM, Jiang P, Padley RJ

Publikováno v: Vascular Health and Risk Management, Vol 2012, Iss default, Pp 39-44 (2012)

Peter P Toth1, Kamlesh M Thakker2, Ping Jiang2, Robert J Padley21University of Illinois College of Medicine, Peoria, and CGH Medical Center, Sterling, 2Abbott, Abbott Park, IL, USABackground: The purpose of this research was to compare the effects of

Externí odkaz: https://doaj.org/article/8e395486deb8400592ea0e54cbc164e1

In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494).

Autor: Parmentier JM; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Voss J; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Graff C; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Schwartz A; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Argiriadi M; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Friedman M; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Camp HS; 2Immunology Clinical Development, AbbVie, 1 North Waukegan Rd, North Chicago, IL 60064 USA., Padley RJ; 2Immunology Clinical Development, AbbVie, 1 North Waukegan Rd, North Chicago, IL 60064 USA., George JS; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Hyland D; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Rosebraugh M; 3Clinical Pharmacology and Pharmacometrics, AbbVie, North Chicago, IL USA., Wishart N; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Olson L; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA., Long AJ; 1Immunology Discovery Research, AbbVie Bioresearch Center, 100 Research Dr, Worcester, MA 01605 USA.

Publikováno v: BMC rheumatology [BMC Rheumatol] 2018 Aug 28; Vol. 2, pp. 23. Date of Electronic Publication: 2018 Aug 28 (Print Publication: 2018).

Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.

Autor: Fleischmann RM; University of Texas Southwestern Medical Center at Dallas., Wagner F; Charité Research Organisation, Berlin, Germany., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, Pennsylvania., Mansikka HT; AbbVie, North Chicago, Illinois., Khan N; AbbVie, North Chicago, Illinois., Othman AA; AbbVie, North Chicago, Illinois., Khatri A; AbbVie, North Chicago, Illinois., Hong F; AbbVie, Worcester, Massachusetts., Jiang P; AbbVie, North Chicago, Illinois., Ruzek M; AbbVie, Worcester, Massachusetts., Padley RJ; AbbVie, North Chicago, Illinois.

Publikováno v: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2017 Dec; Vol. 69 (12), pp. 2283-2291. Date of Electronic Publication: 2017 Nov 08.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.